336 related articles for article (PubMed ID: 23134361)
21. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
Frei CR; Restrepo MI; Mortensen EM; Burgess DS
Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.
Yang Y; Xu F; Shi LY; Diao R; Cheng YS; Chen XY; Jing JY; Wang XD; Shen HH
Chin Med J (Engl); 2012 Feb; 125(4):639-45. PubMed ID: 22490488
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia.
Remmelts HH; Meijvis SC; Heijligenberg R; Rijkers GT; Oosterheert JJ; Bos WJ; Endeman H; Grutters JC; Hoepelman AI; Biesma DH
J Infect; 2012 Jul; 65(1):25-31. PubMed ID: 22410382
[TBL] [Abstract][Full Text] [Related]
24. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
[TBL] [Abstract][Full Text] [Related]
26. Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals.
Hoo Lee J; Hyung Kim Y
Braz J Infect Dis; 2012; 16(4):321-8. PubMed ID: 22846118
[TBL] [Abstract][Full Text] [Related]
27. [Factors effecting the duration of hospitalization and mortality in patients with community-acquired pneumonia].
Pişkin N; Aydemir H; Oztoprak N; Akduman D; Celebi G; Seremet Keskin A
Mikrobiyol Bul; 2009 Oct; 43(4):597-606. PubMed ID: 20084912
[TBL] [Abstract][Full Text] [Related]
28. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
29. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
McCabe C; Kirchner C; Zhang H; Daley J; Fisman DN
Arch Intern Med; 2009 Sep; 169(16):1525-31. PubMed ID: 19752411
[TBL] [Abstract][Full Text] [Related]
30. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
[TBL] [Abstract][Full Text] [Related]
31. Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients.
Liapikou A; Polverino E; Ewig S; Cillóniz C; Marcos MA; Mensa J; Bello S; Martin-Loeches I; Menéndez R; Torres A
Eur Respir J; 2012 Apr; 39(4):855-61. PubMed ID: 21920895
[TBL] [Abstract][Full Text] [Related]
32. Outcomes in females hospitalised with community-acquired pneumonia are worse than in males.
Arnold FW; Wiemken TL; Peyrani P; Mirsaeidi M; Ramirez JA;
Eur Respir J; 2013 May; 41(5):1135-40. PubMed ID: 22835618
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis.
Wan YD; Sun TW; Liu ZQ; Zhang SG; Wang LX; Kan QC
Chest; 2016 Jan; 149(1):209-19. PubMed ID: 26501852
[TBL] [Abstract][Full Text] [Related]
34. Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia.
Lodise TP; Kwa A; Cosler L; Gupta R; Smith RP
Antimicrob Agents Chemother; 2007 Nov; 51(11):3977-82. PubMed ID: 17709460
[TBL] [Abstract][Full Text] [Related]
35. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.
Rello J; Rodriguez A; Lisboa T; Gallego M; Lujan M; Wunderink R
Crit Care Med; 2009 Feb; 37(2):456-62. PubMed ID: 19114916
[TBL] [Abstract][Full Text] [Related]
36. Poor adherence to South African guidelines for the management of community-acquired pneumonia.
Nyamande K; Lalloo UG
S Afr Med J; 2007 Aug; 97(8):601-3. PubMed ID: 17952218
[TBL] [Abstract][Full Text] [Related]
37. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
[TBL] [Abstract][Full Text] [Related]
38. Severity and outcomes of community acquired pneumonia in asthmatic patients.
Terraneo S; Polverino E; Cilloniz C; Amaro R; Vennera Mdel C; Gabarrus A; Montull B; Moreno E; Menendez R; Centanni S; Torres A
Respir Med; 2014 Nov; 108(11):1713-22. PubMed ID: 25245791
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiology, clinical aspects and prognosis of severe progressive community-acquired pneumonia].
Höltermann W; Krämer M; Geppert P; van Wickern M; Lukasewitz P
Pneumologie; 1998 May; 52(5):263-70. PubMed ID: 9654975
[TBL] [Abstract][Full Text] [Related]
40. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia.
Jasti H; Mortensen EM; Obrosky DS; Kapoor WN; Fine MJ
Clin Infect Dis; 2008 Feb; 46(4):550-6. PubMed ID: 18194099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
